Literature DB >> 17950725

CD8+ T cells contribute to macrophage accumulation and airspace enlargement following repeated irritant exposure.

Michael T Borchers1, Scott C Wesselkamper, Nathaniel L Harris, Hitesh Deshmukh, Erin Beckman, Mark Vitucci, Jay W Tichelaar, George D Leikauf.   

Abstract

BACKGROUND: Persistent macrophage accumulation and alveolar enlargement are hallmark features of chronic obstructive pulmonary disease (COPD). A role for CD8(+) lymphocytes in the development of COPD is suggested based on observations that this T cell subset is increased in the airways and parenchyma of smokers that develop COPD with airflow limitation. In this study, we utilize a mouse model of COPD to examine the contributions of CD8(+) T cells in the persistent macrophage accumulation and airspace enlargement resulting from chronic irritant exposure.
METHODS: We analyzed pulmonary inflammation and alveolar destruction in wild-type and Cd8-deficient mice chronically exposed to acrolein, a potent respiratory tract irritant. We further examined cytokine mRNA expression levels by RNase protection assay, matrix metalloproteinase (MMP) activity by gelatin zymography, and epithelial cell apoptosis by active caspase3 immunohistochemistry in wild-type and Cd8-deficient mice exposed chronically to acrolein.
RESULTS: These studies demonstrate that CD8(+) T cells are important mediators of macrophage accumulation in the lung and the progressive airspace enlargement in response to chronic acrolein exposures. The expression of several inflammatory cytokines (IP-10, IFN-gamma, IL-12, RANTES, and MCP-1), MMP2 and MMP9 gelatinase activity, and caspase3 immunoreactivity in pulmonary epithelial cells were attenuated in the Cd8-deficient mice compared to wild-type.
CONCLUSIONS: These results indicate that CD8(+) T cells actively contribute to macrophage accumulation and the development of irritant-induced airspace enlargement.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17950725      PMCID: PMC2140237          DOI: 10.1016/j.yexmp.2007.08.020

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  55 in total

Review 1.  Inflammation of the airways and lung parenchyma in COPD: role of T cells.

Authors:  Manuel G Cosio; Joaquim Majo; Monica G Cosio
Journal:  Chest       Date:  2002-05       Impact factor: 9.410

2.  Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease.

Authors:  Marina Saetta; Margherita Mariani; Paola Panina-Bordignon; Graziella Turato; Cecilia Buonsanti; Simonetta Baraldo; Cinzia M Bellettato; Alberto Papi; Lorenzo Corbetta; Renzo Zuin; Francesco Sinigaglia; Leonardo M Fabbri
Journal:  Am J Respir Crit Care Med       Date:  2002-05-15       Impact factor: 21.405

Review 3.  Stress management: MHC class I and class I-like molecules as reporters of cellular stress.

Authors:  Michael Gleimer; Peter Parham
Journal:  Immunity       Date:  2003-10       Impact factor: 31.745

Review 4.  Measurement of pulmonary emphysema.

Authors:  W M Thurlbeck
Journal:  Am Rev Respir Dis       Date:  1967-05

5.  Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease.

Authors:  Richard E K Russell; Sarah V Culpitt; Carmen DeMatos; Louise Donnelly; Michael Smith; John Wiggins; Peter J Barnes
Journal:  Am J Respir Cell Mol Biol       Date:  2002-05       Impact factor: 6.914

Review 6.  Pathophysiology of airflow limitation in chronic obstructive pulmonary disease.

Authors:  James C Hogg
Journal:  Lancet       Date:  2004 Aug 21-27       Impact factor: 79.321

7.  Aberrant lung structure, composition, and function in a murine model of Hermansky-Pudlak syndrome.

Authors:  Timothy A Lyerla; Michael E Rusiniak; Michael Borchers; Gerald Jahreis; Jian Tan; Patricia Ohtake; Edward K Novak; Richard T Swank
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-05-30       Impact factor: 5.464

8.  A murine model of cigarette smoke-induced pulmonary inflammation using intranasally administered smoke-conditioned medium.

Authors:  Laura M Miller; W Michael Foster; Donna M Dambach; Darryl Doebler; Murray McKinnon; Loran Killar; Malinda Longphre
Journal:  Exp Lung Res       Date:  2002-09       Impact factor: 2.459

Review 9.  Chronic obstructive pulmonary disease: molecular and cellular mechanisms.

Authors:  P J Barnes; S D Shapiro; R A Pauwels
Journal:  Eur Respir J       Date:  2003-10       Impact factor: 16.671

10.  Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow.

Authors:  Min Jong Kang; Yeon-Mok Oh; Jae Cheol Lee; Dong Gyu Kim; Myung Jae Park; Myung Goo Lee; In Gyu Hyun; Sung Koo Han; Young-Soo Shim; Ki-Suck Jung
Journal:  J Korean Med Sci       Date:  2003-12       Impact factor: 2.153

View more
  16 in total

1.  Exposure to acrolein by inhalation causes platelet activation.

Authors:  Srinivas D Sithu; Sanjay Srivastava; Maqsood A Siddiqui; Elena Vladykovskaya; Daniel W Riggs; Daniel J Conklin; Petra Haberzettl; Timothy E O'Toole; Aruni Bhatnagar; Stanley E D'Souza
Journal:  Toxicol Appl Pharmacol       Date:  2010-08-03       Impact factor: 4.219

Review 2.  Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease.

Authors:  Hongwei Yao; Irfan Rahman
Journal:  Toxicol Appl Pharmacol       Date:  2011-02-04       Impact factor: 4.219

3.  Chronic cigarette smoke exposure generates pathogenic T cells capable of driving COPD-like disease in Rag2-/- mice.

Authors:  Gregory T Motz; Bryan L Eppert; Scott C Wesselkamper; Jennifer L Flury; Michael T Borchers
Journal:  Am J Respir Crit Care Med       Date:  2010-02-04       Impact factor: 21.405

4.  Pneumocystis murina infection and cigarette smoke exposure interact to cause increased organism burden, development of airspace enlargement, and pulmonary inflammation in mice.

Authors:  Paul J Christensen; Angela M Preston; Tony Ling; Ming Du; W Bradley Fields; Jeffrey L Curtis; James M Beck
Journal:  Infect Immun       Date:  2008-05-19       Impact factor: 3.441

5.  Nonredundant functions of alphabeta and gammadelta T cells in acrolein-induced pulmonary pathology.

Authors:  Michael T Borchers; Scott C Wesselkamper; Bryan L Eppert; Gregory T Motz; Maureen A Sartor; Craig R Tomlinson; Mario Medvedovic; Jay W Tichelaar
Journal:  Toxicol Sci       Date:  2008-05-29       Impact factor: 4.849

6.  Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease.

Authors:  Michael T Borchers; Scott C Wesselkamper; Victor Curull; Alba Ramirez-Sarmiento; Albert Sánchez-Font; Judith Garcia-Aymerich; Carlos Coronell; Josep Lloreta; Alvar G Agusti; Joaquim Gea; John A Howington; Michael F Reed; Sandra L Starnes; Nathaniel L Harris; Mark Vitucci; Bryan L Eppert; Gregory T Motz; Kevin Fogel; Dennis W McGraw; Jay W Tichelaar; Mauricio Orozco-Levi
Journal:  J Clin Invest       Date:  2009-02-09       Impact factor: 14.808

7.  Acrolein induces endoplasmic reticulum stress and causes airspace enlargement.

Authors:  Yoshiaki Kitaguchi; Laimute Taraseviciene-Stewart; Masayuki Hanaoka; Ramesh Natarajan; Donatas Kraskauskas; Norbert F Voelkel
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

8.  Enhancement of the acrolein-induced production of reactive oxygen species and lung injury by GADD34.

Authors:  Yang Sun; Sachiko Ito; Naomi Nishio; Yuriko Tanaka; Nana Chen; Lintao Liu; Ken-ichi Isobe
Journal:  Oxid Med Cell Longev       Date:  2015-03-03       Impact factor: 6.543

9.  Lung CD8+ T cells in COPD have increased expression of bacterial TLRs.

Authors:  Christine M Freeman; Fernando J Martinez; Meilan K Han; George R Washko; Alexandra L McCubbrey; Stephen W Chensue; Douglas A Arenberg; Catherine A Meldrum; Lisa McCloskey; Jeffrey L Curtis
Journal:  Respir Res       Date:  2013-02-01

Review 10.  Probiotics in the management of lung diseases.

Authors:  Esmaeil Mortaz; Ian M Adcock; Gert Folkerts; Peter J Barnes; Arjan Paul Vos; Johan Garssen
Journal:  Mediators Inflamm       Date:  2013-05-08       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.